Atención farmacéutica a paciente de 68 años con diagnóstico de diabetes mellitus tipo ii administrando insulina como tratamiento farmacológico electivo

Abstract

Diabetes mellitus is a disease caused by obesity, sedentary lifestyle, family history of type 2 diabetes, people over 40 years of age, ingestion of saturated fat and hing blood pressure. The knowledge of risk factors will allow the development of preventive activities, promoters and health policies in the population and decrease the rates of the disease and its complications. The OMS in 2014 reveals 422 million people aged 20 to 79 years diagnosed with Diabetes Mellitus; it will be the seventh cause of mortality for 2030; in Ecuador; it constitutes the first cause of mortality with 7.44% and a mortality rate of 29.76. A descriptive and analytical method of study was applied. The main objective of this research is to develop a pharmaceutical care program through health education, pharmacotherapy monitoring, healthy lifestyle habits, to prevent or delay the appearance of complications associated with the disease. A pharmaceutical care program is proposed for the patient, the problems related to the medication are indentified, detecting that she received an incomplete pharmacotherapy (potential problem) and was administered hypoglycaemic medication without monthly control of the glycemia (real problem). Problems related to pharmacotherapy are prevented and solved, the administration of a medication without a valiadated indication or control examinations being of high priority. Sugar levels are stabilized, to solve problems related to medications and the prevention of complications derived from the disease such as ulcerations, diabetic foot, neuropathy, retinopathy and nephropathy.